Serious Infections Due to Known or Suspected Gram-positive Pathogens

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Serious Infections Due to Known or Suspected Gram-positive Pathogens trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

CompletedPhase 1

NCT01791049

TD-1607 SAD Study in Healthy Subjects

TD-1607, administered intravenously as single doses, will be investigated in healthy subjects to assess its tolerability, safety, and pharmacokinetics.

United States64 participantsStarted 2013-04

Treatment: TD-1607, Placebo